Cloning and Characterization of the Promoter Regions of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene: Analysis of Deoxyribonucleic Acid from Normal Subjects and Patients with Pseudohypoparathyroidism Type 1b

• Published in: The journal of clinical endocrinology and metabolism Vol. 82; no. 4; pp. 1031 - 1040
• Main Author: Bettoun, J. D.
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Endocrine Society 01.04.1997
• Subjects: Adolescent; Animals; Base Sequence; Biological and medical sciences; Child; Child, Preschool; Chromosome Mapping; Cloning, Molecular; DNA - genetics; Endocrinopathies; Female; Genes; Genome; Humans; Male; Medical sciences; Mice; Molecular Sequence Data; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases); Promoter Regions, Genetic; Pseudohypoparathyroidism - genetics; Receptor, Parathyroid Hormone, Type 1; Receptors, Parathyroid Hormone - genetics; Reference Values; Endocrinopathy; Human; Genetic inheritance; Pathogenesis; Gene expression; Genetic disease; Promoter; Gene; DNA; Pseudohypoparathyroidism; Parathyroid hormone related peptide; Molecular cloning; Biological receptor
• ISSN: 0021-972X
• DOI: 10.1210/jc.82.4.1031

Expression of the PTH/PTH-related peptide (PTHrP) receptor (PTHR) in the mouse is controlled by at least two promoters. The downstream promoter (P2) is ubiquitously expressed, whereas expression of the upstream promoter (P1) is largely restricted to kidney. These observations may provide a genetic basis for a human PTH resistance syndrome, pseudohypoparathyroidism type 1b (PHP1b), in which renal, but not osseous, signaling by PTH is defective. We, therefore, cloned and characterized the 5'-end of the human PTHR gene and found that its organization is very similar to that of the mouse. Transcription initiation sites of human P1 and P2 promoters are in similar, but not identical, positions to those of the mouse gene. The identification of a human P2 promoter is significant because no P2-specific human PTHR complementary DNAs have been isolated to date. Southern analysis of genomic DNA from seven PHP1b patients did not reveal any rearrangements in proximal promoter regions or exons encoding 5'-untranslated region sequences. No significant sequence differences were found in clones of normal and patient DNAs encompassing proximal promoter sequences, and untranslated region and signal sequence exons. Thus, in the seven PHP1b patients analyzed, no defects were identified that would influence initiation site selection, stability, or splicing of renal PTHR transcripts. These data indicate that the genetic defect(s) in PHP1b in these patients lies in distal enhancer elements of the gene, in an essential transcriptional regulator, or in some as yet unidentified cofactor required for renal PTH signaling.